Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 34,229,800 cases with around 609,870 deaths. India confirmed a total of at least 31,257,720 cases and 418,980 deaths, while Brazil reported over 19,473,950 COVID-19 cases with 545,600 deaths. In total, there were at least 192,054,100 cases of COVID-19 worldwide with more than 4,128,050 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Information technology shares climbed 0.6% on Thursday. Meanwhile, top gainers in the sector included ACM Research, Inc. ACMR 3.95%, up 4%, and Veritone, Inc. VERI 4.33%, up 4%.

In trading on Thursday, energy shares fell 1.2%.

Top Headline

AT&T Inc. T 0.29% reported better-than-expected results for its second quarter.

AT&T reported quarterly adjusted earnings of $0.89 per share, beating analysts’ estimates of $0.79 per share. The company’s revenue came in at $44.05 billion, versus expectations of $42.64 billion.

AT&T said it expects FY21 sales growth in the 2-3% range and also projects adjusted EPS to grow in the mid to mid-single digits.

Equities Trading UP

NRx Pharmaceuticals, Inc. NRXP 46.09% shares shot up 45% to $14.69 as the company said it has validated the first commercial formulation of Zyesami for intravenous use, allowing for high volume manufacturing, with an anticipated one year or greater stability under appropriate storage conditions.

Shares of Summit Wireless Technologies, Inc. WISA 32.68% got a boost, shooting 31% to $5.34 after the company highlighted the launch of its Amazon storefront.

ImmunoPrecise Antibodies Ltd. IPA 169.59% shares were also up, gaining 143% to $13.47 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity against the SARS-CoV-2 Delta (B.1.617.2) variant.

Equities Trading DOWN

Seres Therapeutics, Inc. MCRB 55.6% shares tumbled 55% to $9.40 after the company announced topline results from the Phase 2b ECO-RESET study evaluating SER-287 in patients with mild-to-moderate ulcerative colitis (UC). The study did not meet its primary endpoint of improving clinical remission rates compared to placebo.

Shares of TRACON Pharmaceuticals, Inc. TCON 23.83% were down 24% to $3.7450 after the company announced it increased a previously announced bought deal offering of common stock to $15 million.

Jupiter Wellness, Inc. JUPW 24.38% was down, falling 24% to $2.12 after the company announced pricing of a $32.5 million underwritten public offering of common stock and warrants.

Commodities

In commodity news, oil traded up 1.5% to $71.40, while gold traded up 0.2% to $1,806.60.

Silver traded up 0.6% Thursday to $25.405 while copper rose 1.3% to $4.3275.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.56%, the Spanish Ibex Index rose 0.64% and the German DAX 30 gained 0.35%. Meanwhile, the London’s FTSE 100 fell 0.56%, French CAC 40 surged 0.17% and Italy’s FTSE MIB climbed 0.53%.

The European Central Bank announced plans to keep interest rates and asset purchases unchanged. The manufacturing climate indicator in France climbed to 110 in July from a revised reading of 108 in the prior month. The CBI's quarterly gauge of manufacturing optimism for the UK declined to 27 in the third quarter compared to 38 in the prior three-month period.

Economics

US initial jobless claims rose to 419,000 in the latest week, versus a revised reading of 368,000 in the previous week.

The Chicago Fed National Activity Index fell to 0.09 in June from a revised reading of 0.26 in May.

Existing home sales rose 1.4% to 5.86 million in June.

The index of leading economic indicators rose 0.7% for June.

The Kansas City Fed's manufacturing production index surged to a record high of 41 in July versus 30 in the prior month.

Benzinga does not provide investment advice. All rights reserved.

Recommended Content


Recommended Content

Editors’ Picks

USD/JPY off lows, stays pressured near 142.50 ahead of BoJ policy decision

USD/JPY off lows, stays pressured near 142.50 ahead of BoJ policy decision

USD/JPY has bounced off lows but remains pressured near 142.50 in the Asian session on Friday. Markets turn risk-averse and flock to the safety in the Japanese Yen while the Fed-BoJ policy divergence and hot Japan's CPI data also support the Yen ahead of the BoJ policy verdict. 

USD/JPY News
AUD/USD bears attack 0.6800 amid PBOC's status-quo, cautious mood

AUD/USD bears attack 0.6800 amid PBOC's status-quo, cautious mood

AUD/USD attacks 0.6800 in Friday's Asian trading, extending its gradual retreat after the PBOC unexpectedly left mortgage lending rates unchanged in September. A cautious market mood also adds to the weight on the Aussie. Fedspeak eyed. 

AUD/USD News
Gold price treads water below record peak, awaits Fedspeak

Gold price treads water below record peak, awaits Fedspeak

Gold price hovers below the all-time peak touched earlier this week amid a bearish US Dollar and rising bets for more upcoming rate cuts by the Fed. Concerns over an economic downturn in China keep the safe-haven Gold price afloat. Fedspeak remains on tap. 

Gold News
Bank of Japan set to keep rates on hold after July’s hike shocked markets

Bank of Japan set to keep rates on hold after July’s hike shocked markets

The Bank of Japan is expected to keep its short-term interest rate target between 0.15% and 0.25% on Friday, following the conclusion of its two-day monetary policy review. The decision is set to be announced during the early Asian session. 

Read more
XRP eyes gains as Ripple gears up for stablecoin launch, Grayscale XRP Trust notes rising NAV

XRP eyes gains as Ripple gears up for stablecoin launch, Grayscale XRP Trust notes rising NAV

Ripple (XRP) gained 2.3% since the start of the week. The altcoin’s gains are likely powered by key market movers that include Ripple USD (RUSD) stablecoin, Grayscale XRP Trust performance and the demand for the altcoin among institutional investors.

Read more
Moneta Markets review 2024: All you need to know

Moneta Markets review 2024: All you need to know

VERIFIED In this review, the FXStreet team provides an independent and thorough analysis based on direct testing and real experiences with Moneta Markets – an excellent broker for novice to intermediate forex traders who want to broaden their knowledge base.

Read More

Majors

Cryptocurrencies

Signatures